PFG Investments LLC Sells 1,840 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

PFG Investments LLC reduced its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.5% in the fourth quarter, HoldingsChannel reports. The firm owned 6,726 shares of the exchange traded fund’s stock after selling 1,840 shares during the period. PFG Investments LLC’s holdings in SPDR S&P Biotech ETF were worth $601,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in XBI. Roundview Capital LLC grew its stake in shares of SPDR S&P Biotech ETF by 275.4% in the 1st quarter. Roundview Capital LLC now owns 7,599 shares of the exchange traded fund’s stock valued at $683,000 after buying an additional 5,575 shares during the period. U.S. Capital Wealth Advisors LLC acquired a new stake in SPDR S&P Biotech ETF in the first quarter valued at approximately $222,000. Synovus Financial Corp increased its holdings in shares of SPDR S&P Biotech ETF by 559.1% during the first quarter. Synovus Financial Corp now owns 15,462 shares of the exchange traded fund’s stock valued at $1,390,000 after acquiring an additional 13,116 shares in the last quarter. Vontobel Holding Ltd. raised its position in shares of SPDR S&P Biotech ETF by 6.7% during the first quarter. Vontobel Holding Ltd. now owns 6,400 shares of the exchange traded fund’s stock worth $575,000 after purchasing an additional 400 shares during the period. Finally, Sequoia Financial Advisors LLC raised its position in shares of SPDR S&P Biotech ETF by 17.6% during the first quarter. Sequoia Financial Advisors LLC now owns 2,234 shares of the exchange traded fund’s stock worth $201,000 after purchasing an additional 334 shares during the period.

SPDR S&P Biotech ETF Trading Up 2.4 %

NYSEARCA XBI opened at $94.91 on Thursday. The company has a market cap of $7.28 billion, a P/E ratio of 11.47 and a beta of 0.97. The company has a fifty day simple moving average of $93.27 and a 200 day simple moving average of $82.57. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.